Antibody developed to protect immune system cells in vitro from a dangerous hospital-acquired bacterium

A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), has demonstrated in cell cultures that it can…

Continue Reading

News Source: medicalxpress.com